Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

NCT00001087

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Northwestern University CRS Chicago, Illinois, United States
  • Cook County Hosp. CORE Ctr. Chicago, Illinois, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details
Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers

NCT00001090

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • JHU AVEG Baltimore, Maryland, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

A Study of HIV-Disease Development in Aging

NCT00006144

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
View all 45 locations
View Trial Details
Completed

Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

NCT00038259

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • Univ. of California Davis Med. Ctr., ACTU Sacramento, California, United States
View Trial Details
Completed

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants

NCT00001135

Conditions
Blood-Borne Infections, Communicable Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Univ of Alabama at Birmingham - Pediatric Birmingham, Alabama, United States
  • UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla, California, United States
  • UCLA Med Ctr / Pediatric Los Angeles, California, United States
  • UCSF / Moffitt Hosp - Pediatric San Francisco, California, United States
View all 20 locations
View Trial Details
Completed

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

NCT00036452

Conditions
Behavior, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • USC CRS Los Angeles, California, United States
  • Univ. of California Davis Med. Ctr., ACTU Sacramento, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 29 locations
View Trial Details
Completed

Intensive Viral Dynamics Substudy of A5248

NCT00852618

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • IHV Baltimore Treatment CRS Baltimore, Maryland, United States
  • Johns Hopkins University CRS Baltimore, Maryland, United States
  • Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

NCT00001133

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details

Related conditions